MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, AYTU made $15,165K in revenue. -$10,584K in net income. Net profit margin of -69.79%.

Income Overview

Revenue
$15,165K
Net Income
-$10,584K
Net Profit Margin
-69.79%
EPS
-$1.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • ADHDPortfolio
    • The Pediatric Portfolio
    • EXXUAPortfolio
    • Product And Service Other

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Net revenue
15,165 13,888 15,678 18,452
Cost of goods sold
5,541 4,702 5,158 5,646
Gross profit
9,624 9,186 10,520 12,806
Selling and marketing
5,998 5,322 5,027 5,194
General and administrative
5,070 4,924 4,073 4,109
Research and development
0 0 369 162
Amortization of intangible assets
526 444 921 920
Restructuring costs
0 0 439 -
Impairment expense
--4,351 -
Total operating expenses
11,594 10,690 15,179 10,385
Loss from operations
-1,970 -1,504 -4,659 2,421
Other income, net
190 201 -545 36
Interest expense
560 516 905 900
Derivative warrant liabilities (loss) gain
-8,244 3,784 -3,422 2,261
Loss on extinguishment of debt
--0 -
(loss) income from continuing operations before income tax expense
-10,584 1,965 -9,530 3,818
Income tax benefit (expense)
0 0 77 -122
Net (loss) income from continuing operations
-10,584 1,965 -9,607 3,940
Net income from discontinued operations, net of tax
0 0 189 54
Net (loss) income
-10,584 1,965 -9,515 3,994
Basic - net (loss) income (in dollars per share)
-1.05 0.21 -1.525 0.65
Basic weighted-average common shares outstanding (note 17) (in shares)
10,036,359 9,441,073 -2,961,454.5 6,134,634
Diluted - net loss (in dollars per share)
-1.05 -0.08 -0.21
Diluted weighted-average common shares outstanding (note 17) (in shares)
10,036,359 19,476,635 -8,204,453
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$10,584K Net (loss) incomefrom continuing...-$10,584K Product And ServiceOther$19K The PediatricPortfolio$1,689K ADHDPortfolio$13,216K EXXUAPortfolio$241K (loss) income fromcontinuing operations...-$10,584K Other income, net$190K Net revenue$15,165K Derivative warrantliabilities (loss) gain-$8,244K Interest expense$560K Loss from operations-$1,970K Gross profit$9,624K Cost of goods sold$5,541K Total operatingexpenses$11,594K Amortization of intangibleassets$526K General andadministrative$5,070K Selling and marketing$5,998K

AYTU BIOPHARMA, INC (AYTU)

AYTU BIOPHARMA, INC (AYTU)